Unknown

Dataset Information

0

RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.


ABSTRACT: Epithelial-msenchymal transition (EMT) is closely associated with cancer and tissue fibrosis. The nuclear accumulation of myocardin-related transcription factor A (MRTF-A/MAL/MKL1) plays a vital role in EMT. In various cells treated with CCG-1423, a novel inhibitor of Rho signaling, the nuclear accumulation of MRTF-A is inhibited. However, the molecular target of this inhibitor has not yet been identified. In this study, we investigated the mechanism of this effect of CCG-1423. The interaction between MRTF-A and importin ?/?1 was inhibited by CCG-1423, but monomeric G-actin binding to MRTF-A was not inhibited. We coupled Sepharose with CCG-1423 (CCG-1423 Sepharose) to investigate this mechanism. A pull-down assay using CCG-1423 Sepharose revealed the direct binding of CCG-1423 to MRTF-A. Furthermore, we found that the N-terminal basic domain (NB) of MRTF-A, which acts as a functional nuclear localization signal (NLS) of MRTF-A, was the binding site for CCG-1423. G-actin did not bind to CCG-1423 Sepharose, but the interaction between MRTF-A and CCG-1423 Sepharose was reduced in the presence of G-actin. We attribute this result to the high binding affinity of MRTF-A for G-actin and the proximity of NB to G-actin-binding sites (RPEL motifs). Therefore, when MRTF-A forms a complex with G-actin, the binding of CCG-1423 to NB is expected to be blocked. NF-E2 related factor 2, which contains three distinct basic amino acid-rich NLSs, did not bind to CCG-1423 Sepharose, but other RPEL-containing proteins such as MRTF-B, myocardin, and Phactr1 bound to CCG-1423 Sepharose. These results suggest that the specific binding of CCG-1423 to the NLSs of RPEL-containing proteins. Our proposal to explain the inhibitory action of CCG-1423 is as follows: When the G-actin pool is depleted, CCG-1423 binds specifically to the NLS of MRTF-A/B and prevents the interaction between MRTF-A/B and importin ?/?1, resulting in inhibition of the nuclear import of MRTF-A/B.

SUBMITTER: Hayashi K 

PROVIDER: S-EPMC3928398 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.

Hayashi Ken'ichiro K   Watanabe Bunta B   Nakagawa Yoshiaki Y   Minami Saki S   Morita Tsuyoshi T  

PloS one 20140218 2


Epithelial-msenchymal transition (EMT) is closely associated with cancer and tissue fibrosis. The nuclear accumulation of myocardin-related transcription factor A (MRTF-A/MAL/MKL1) plays a vital role in EMT. In various cells treated with CCG-1423, a novel inhibitor of Rho signaling, the nuclear accumulation of MRTF-A is inhibited. However, the molecular target of this inhibitor has not yet been identified. In this study, we investigated the mechanism of this effect of CCG-1423. The interaction b  ...[more]

Similar Datasets

2013-05-01 | E-GEOD-30188 | biostudies-arrayexpress
2013-05-01 | GSE30188 | GEO
| S-EPMC3678708 | biostudies-literature
| S-EPMC7006939 | biostudies-literature
| S-EPMC5985144 | biostudies-other
| S-EPMC2223415 | biostudies-literature
| S-EPMC4546662 | biostudies-literature
2023-09-28 | GSE244232 | GEO
2023-10-03 | GSE244231 | GEO
2023-09-26 | GSE243873 | GEO